Special Issue

Management of Breast Cancer

Submission Deadline: 31 Jul 2022

Guest Editor

  • Portrait of Guest Editor San-Gang Wu

    San-Gang Wu MD

    Department of Radiation Oncology, The First Affiliated Hospital of Xiamen University, Xiamen, China

    Interests: Breast cancer; Radiotherapy; Biologic markers; Staging; Treatment decision-making

    Special Issue in IMR Press journals

Special Issue Information

Dear Colleagues,

Breast cancer is the most common malignant tumor in women. With extensive research into the clinicopathological and molecular features of breast cancer, the survival of breast cancer has now been significantly improved.

In this Special Issue, we seek to highlight the role of locoregional and systemic management in breast cancer with curative or palliative intent. Controversies remain regarding axillary management, breast reconstruction, locoregional management in de novo stage breast cancer, postmastectomy radiotherapy in stage T1-2N0 disease, and the role of new pathological prognostic staging in treatment decision-making. In addition, identifying potential factors for predicting the effect of locoregional and systemic treatment are also worthy of further study.

For this Special Issue, we hope to provide new information on locoregional and systemic management in breast cancer that may contribute to improved outcomes for these patients.

Dr.  San-Gang Wu

Guest Editor

Keywords

  • Breast cancer
  • Surgery
  • Chemotherapy
  • Endocrine therapy
  • Target therapy
  • Radiotherapy
  • Management

Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. 

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.